Moritz, Eileen	65384
Reference intervals for Serum Sphingosine-1-Phosphate in the Population-based Study of Health in Pomerania
Data on subgroup specific baseline characteristics and serum sphingosine-1-phosphate concentrations in the Study of Health in Pomerania.
Platelet activation and platelet-leucocyte-conjugate formation in the blood of glioblastoma patients
Targeting sphingosine-1-phosphate lyase as an anabolic therapy for bone loss
Acetylsalicylsäure zur Darmkrebsprävention -  Ein Update zum Crosstalk zwischen Thrombozyten und Tumorzellen
The Role of Platelets in Cancer Pathophysiology: Focus on Malignant Glioma.
Analyses of sphingosine-1-phosphate in the context of transfusion: how much is in stored blood products and in patient blood?
Determinants of Serum- and Plasma Sphingosine-1-Phosphate Concentrations in a Healthy Study Group.
Increased sphingosine-1-phosphate serum concentrations in subjects with periodontal disease: a matter of inflammation
Reference ranges for sphingosine-1-phosphate in neonates.
Dynamics of Vascular Protective and Immune Supportive Sphingosine-1-Phosphate During Cardiac Surgery
Pleiotropic Effects of the Protease-Activated Receptor 1 (PAR1) Inhibitor, Vorapaxar, on Atherosclerosis and Vascular Inflammation.
Specific inhibition of the transporter MRP4/ABCC4 affects multiple signaling pathways and thrombus formation in human platelets.
Sphingosine-1-phosphate and vascular disease in the general population
Reference Interval for Serum L-Homoarginine Determined with Enzyme-Linked Immunosorbent Assay in the Population-Based Study of Health in Pomerania.
Comparison of learning success in pharmacological education between face-to-face and online teaching during the COVID pandemic
Platelet-Derived S1P and Its Relevance for the Communication with Immune Cells in Multiple Human Diseases
Sphingosine-1-phosphate levels are inversely associated with left ventricular and atrial chamber volume and cardiac mass in men : The Study of Health in Pomerania (SHIP)